Johnny Ek
2023 - Akoya Biosciences
In 2023, Johnny Ek earned a total compensation of $2.3M as Chief Financial Officer at Akoya Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $118,269 |
|---|---|
| Option Awards | $659,760 |
| Salary | $313,889 |
| Stock Awards | $1,216,000 |
| Other | $1,826 |
| Total | $2,309,744 |
Ek received $1.2M in stock awards, accounting for 53% of the total pay in 2023.
Ek also received $118.3K in non-equity incentive plan, $659.8K in option awards, $313.9K in salary and $1.8K in other compensation.
Rankings
In 2023, Johnny Ek's compensation ranked 437th out of 2,978 executives tracked by ExecPay. In other words, Ek earned more than 85.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 437 out of 2,978 | 85th |
Division Manufacturing | 248 out of 1,637 | 85th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 27 out of 256 | 90th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 3 out of 53 | 94th |
Industry Laboratory Analytical Instruments | 3 out of 18 | 83rd |
Source: SEC filing on April 23, 2024.
Ek's colleagues
We found two more compensation records of executives who worked with Johnny Ek at Akoya Biosciences in 2023.